Related Experiment Video
Updated: Jul 28, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.8K
Hepatitis C in Egypt - past, present, and future.
Ahmed Elgharably1, Asmaa I Gomaa2, Mary Me Crossey1
1Division of Digestive Health, Department of Surgery and Cancer, St Mary's Hospital, Imperial College London, London, UK; National Liver Institute, Menoufiya University, Shebeen El Kom, Egypt.
International Journal of General Medicine
|January 6, 2017
Summary
Egypt faces significant Hepatitis C challenges due to historical mass treatments and current access barriers to new antiviral drugs. Addressing these requires overcoming cost, population growth, and infection control issues.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Egypt has the world's highest Hepatitis C virus (HCV) prevalence.
- Mass antischistosomal treatment with tartar emetic injections (1950s-1980s) is linked to widespread HCV infection.
- WHO advised on these historical public health interventions.
Approach:
- Review of historical treatment schemes and current therapeutic strategies for HCV in Egypt.
- Analysis of treatment efficacy, cost barriers, and ongoing disease control challenges.
- Examination of factors contributing to persistent HCV burden, including population growth and infection control.
Key Points:
- HCV treatment has evolved from PEGylated interferon to highly effective direct-acting antiviral drugs (>90% efficacy).
- High cost of novel treatments limits accessibility for the Egyptian population.
- Inadequate infection control practices exacerbate the HCV public health crisis.
Conclusions:
- Despite advances in antiviral therapies, Egypt's HCV epidemic persists.
- Socioeconomic factors and healthcare system limitations hinder effective HCV control.
- Integrated strategies addressing treatment access and infection prevention are crucial for Egypt's public health.
Related Concept Videos
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...